Review Article
Increased Risk of Cancer in relation to Gout: A Review of Three Prospective Cohort Studies with 50,358 Subjects
Table 2
Summary of meta-analysis results.
| Type of cancer | aRR [95% CI] | value for pooled analysis | (%) | value for heterogeneity analysis |
| All | 1.42 [1.09–1.84] | 0.008 | 98.1 | <0.001 | Males | 1.67 [0.93–3.01] | 0.087 | 99.0 | <0.001 | Urological cancers | 1.72 [1.30–2.26] | <0.001 | 90.7 | <0.001 | Digestive system cancers | 1.39 [1.23–1.56] | <0.001 | 68.2 | <0.001 | Lung cancer | 1.29 [1.01–1.65] | 0.039 | 75.5 | 0.007 | Breast cancer | 0.92 [0.77–1.09] | 0.336 | 45.9 | 0.174 | Brain cancer | 1.24 [0.82–1.87] | 0.309 | 0.0 | 0.946 |
|
|
RR, relative risk; 95% CI, 95% confidence interval.
|